<DOC>
	<DOCNO>NCT01680900</DOCNO>
	<brief_summary>This pilot study determine proof principle vilazodone , selective serotonin reuptake inhibitor 5HT1a agonist , reduce frequency severity menopausal hot flash relative placebo . A secondary aim evaluate improvement menopause-related quality life .</brief_summary>
	<brief_title>Vilazodone Menopausal Hot Flashes</brief_title>
	<detailed_description>This proposal conduct small clinical trial proof principle vilazodone reduce frequency severity menopausal hot flash . An additional exploratory aim identify improvement menopause-related quality life . Healthy , perimenopausal woman age 45-60 average 4 moderate severe hot flashes/night sweat per day 3 screening week randomize 8 week treatment 2:1 ratio vilazodone match placebo pill . Flexible dose vilazodone start 10 mg once/day 7 day , increase 20 mg/day 1 week increase 40 mg once/day week 3 unimproved . The primary outcome assessment frequency severity hot flash week 4 week 8 assess prospective daily diary ( use 7-day mean score daily diary ) . The secondary outcome clinical improvement , define hot flash frequency &gt; =50 % decrease baseline . Treatment-emergent adverse event monitor patient rating tolerability obtain .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Women age 4560 year Amenorrhea 60 day postmenopausal bilateral oophorectomy . 4 moderate severe hot flash night sweat per 24 hour period ( 28/week ) record daily diary 3 screening week . Hot flashes/night sweat rat moderate severe and/or bothersome ( moderately lot ) 4 days/nights screen week . In general good health . Signed informed consent . Psychotropic medication currently within last 30 day . Current use hormonal medication hormone therapy hormonal contraception treatment hot flash ( Prescription , overthecounter herbal ) . Drug alcohol abuse past year . Lifetime diagnosis psychosis bipolar disorder . Suicide attempt past 3 year current suicidal ideation . Current major depression . Not use medically approve , nonhormonal method birth control sexually active postmenopausal ( 12 month since last menstrual period bilateral oophorectomy ) . Pregnancy , intend pregnancy breast feeding . Any severe unstable medical illness , e.g. , breast ovarian cancer , seizure disorder , etc . Current participation another intervention study . Inability unwillingness complete study procedure .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>menopause</keyword>
	<keyword>hot flash</keyword>
	<keyword>vilazodone</keyword>
</DOC>